For instance, the three studies that found a significant increase in MSTN expression in cases versus controls investigated COPD and CKD, the two studies that found a significant decrease in cases versus controls investigated COPD and gastric cancer, whereas the two studies that found a nonsignificant difference in MSTN expression in cases versus controls investigated COPD and lung cancer. This evidence concerns the gene MSTN and lung carcinoma.